Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications.
about
Evaluation of Cancer Metabolomics Using ex vivo High Resolution Magic Angle Spinning (HRMAS) Magnetic Resonance Spectroscopy (MRS)SDHA related tumorigenesis: a new case series and literature review for variant interpretation and pathogenicity.Carney triad, SDH-deficient tumors, and Sdhb+/- mice share abnormal mitochondriaMagnetic resonance spectroscopy of paragangliomas: new insights into in vivo metabolomics18F-FLT PET/CT in the Evaluation of Pheochromocytomas and Paragangliomas: A Pilot Study.Applications of NMR spectroscopy to systems biochemistry.Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas.Pheochromocytoma: The First Metabolic Endocrine Cancer.Identifying mitotane-induced mitochondria-associated membranes dysfunctions: metabolomic and lipidomic approaches.New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification.Implications of SDHB genetic testing in patients with sporadic pheochromocytoma.Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma.New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.18F-fluorodihydroxyphenylalanine PET/CT in pheochromocytoma and paraganglioma: relation to genotype and amino acid transport system L.Metabolic profiling of the three neural derived embryonal pediatric tumors retinoblastoma, neuroblastoma and medulloblastoma, identifies distinct metabolic profiles.Tissue metabolite profiles for the characterisation of paediatric cerebellar tumours
P2860
Q26751944-A30F0CC0-63B0-49B8-8473-BA74711ABD8BQ33718501-88893B50-A6E0-4EF5-9483-09051B525FC2Q35611359-5CB1CB91-A7B9-43B8-8510-48FEC6F1EFD3Q36174425-EDAEBAE1-1160-4878-BA8F-E29AD56542C1Q36342833-2CE2AFBA-9233-432D-A71A-A749C89D51C0Q36849513-1D0EB5FF-8D05-4DE7-B016-A9CCF3F69B35Q39011468-E81EE230-CB70-4C1C-BFB3-10AC73A57246Q42197171-8F33646C-F9BF-4611-8D26-47968CFD4D5CQ47115515-15905DB2-71F9-4FCB-8CB2-9F2B80B5AA0FQ47934716-E1226CF9-FABB-46D9-A683-1BE00DB10E1DQ48823803-291E691C-18F1-426F-A9B9-9D0BF357B925Q49174438-B683989C-7092-439E-B191-F40AFE371DF3Q49948832-762C7E0B-95A3-4A8A-84C0-9BC4341311B2Q50229413-135406D9-4157-45BE-9BFE-40C2CDC8AA00Q51296022-2F4A3517-4097-41C2-993C-F8D6CEF1E91FQ52655039-E18D0998-65FD-4026-AC8C-D0C2A346EC30Q58790908-85F076A8-9D3C-444C-8062-F22A04A8AC36
P2860
Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Metabolome profiling by HRMAS ...... thophysiological implications.
@ast
Metabolome profiling by HRMAS ...... thophysiological implications.
@en
type
label
Metabolome profiling by HRMAS ...... thophysiological implications.
@ast
Metabolome profiling by HRMAS ...... thophysiological implications.
@en
prefLabel
Metabolome profiling by HRMAS ...... thophysiological implications.
@ast
Metabolome profiling by HRMAS ...... thophysiological implications.
@en
P2093
P2860
P50
P1433
P1476
Metabolome profiling by HRMAS ...... thophysiological implications.
@en
P2093
A Ercument Cicek
Alessio Imperiale
Anderson Loundou
Anne Barlier
Bernard Goichot
David Taïeb
François-Marie Moussallieh
Frédéric Sebag
Izzie-Jacques Namer
Karim Elbayed
P2860
P356
10.1016/J.NEO.2014.10.010
P577
2015-01-01T00:00:00Z